Platelet count and platelet indices in women with preeclampsia

Muneera A AlSheeha1, Rafi S Alaboudi1, Mohammad A Alghasham1

  • 1Department of Obstetrics and Gynaecology, College of Medicine, Qassim University, Buriadah.

Insights

Platelet count (PC) below 248.0×10³ /µL and a PC to mean platelet volume (MPV) ratio of 31.2 can predict preeclampsia. These platelet indices offer valuable insights for early detection of this pregnancy complication.

Area of Science:

  • Obstetrics and Gynecology
  • Hematology
  • Reproductive Medicine

Background:

  • Preeclampsia pathophysiology remains incompletely understood.
  • Platelet indices show potential utility in predicting preeclampsia.
  • Early detection of preeclampsia is crucial for maternal and fetal health.

Purpose of the Study:

  • To compare platelet count (PC), mean platelet volume (MPV), platelet distribution width (PDW), and PC to MPV ratio in women with preeclampsia versus healthy controls.
  • To evaluate the diagnostic value of these platelet indices for preeclampsia.

Main Methods:

  • A case-control study was conducted at Qassim Hospital, Kingdom of Saudi Arabia.
  • Sixty preeclamptic women (cases) and sixty healthy pregnant women (controls) were included.
  • Platelet count, MPV, PDW, and PC to MPV ratio were analyzed.

Main Results:

  • No significant differences in age, parity, or BMI between groups.
  • Platelet count (PC) and PC to MPV ratio were significantly lower in preeclamptic women.
  • PDW and MPV did not differ significantly between groups.
  • Receiver operating characteristic (ROC) curve analysis identified a PC cutoff of 248.0×10³ /µL and a PC to MPV ratio cutoff of 31.2 for preeclampsia prediction.

Conclusions:

  • Low platelet count (PC <248.0×10³ /µL) is a significant predictor of preeclampsia.
  • A PC to MPV ratio of 31.2 is also a valid predictor of preeclampsia.
  • These platelet indices can aid in the diagnosis and risk assessment of preeclampsia.
Abstract

Related Concept Videos

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
569
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
500
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.4K